Image credit: Jeremy Buckingham

Advil-Maker GlaxoSmithKline Among Entities Newly Lobbying on Cannabis

From CBD and banking legislation in Congress to the right to advertise in legal states, here are the entities newly lobbying on cannabis-related issues at the national level.

Lobbying
Canada

Canadian Government Launches Review of Cannabis Legalization

The country has allowed legal adult use sales since 2018. A mandated review, which kicked off Thursday, will assess outcomes, from youth use to social and environmental impacts.

Research

NIDA Welcomes Proposals From New Cannabis Suppliers

Today, seven entities meet the basic criteria to compete for a contract to supply the National Institute on Drug Abuse with research-grade cannabis, and it could be worth up to $25 million.

New York

New York Regulators Approve Home Grow Rules for Cannabis Patients

During its first in-person meeting since its formation, the Cannabis Control Board voted to allow for home cultivation to begin for patients next month.